👋 Meet Seegene #ADLM 2024 (formerly AACC)! Under the theme of “One Sample, Many Answers,” we will be showcasing our advanced multiplexing assays that identify multiple targets in a single reaction. We will be waiting to meet you at booth 2442! 🗓 Save the date! What: ADLM 2024 BOLD MOVE. When: July 28–August 1, 2024 Where: McCormick Place Convention Center, Booth 2442 #Seegene #ADLM2024
소개
[INTRODUCING OUR COMPANY] The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses. Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment. With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world. [OUR HISTORY AND OUR FUTURE] Since our founding in 2000, we have been steadfastly focused on molecular diagnostics. Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally. Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID. Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea. In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics. We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.
- 웹사이트
-
https://www.seegene.com/
(주)씨젠 외부 링크
- 업계
- 생명공학 연구
- 회사 규모
- 직원 1,001 - 5,000명
- 본사
- 서울
- 유형
- 상장기업
- 설립
- 2000
- 전문 분야
- in-vitro diagnostics (IVD), companion diagnostics, molecular diagnostic (MoDx), nucleic acid testing (NAT), infectious disease detection, respiratory pathogen detection 및 sexually transmitted disease (STD) detection
위치
(주)씨젠 직원
업데이트
-
The liver is a very important organ, performing over 500 vital functions every day to keep us alive. But hepatitis B and C are silent killers; when symptoms occur, it is too late for treatment. That's why testing, treatment and prevention of viral hepatitis are so important. This #WorldHepatitisDay, let's highlight the importance of early diagnosis and treatment to prevent serious liver disease. 🌍 Together, we can eliminate hepatitis! #Seegene #WorldHepatitisDay2024 #Hepatitis #ItsTimeforAction #AWorldFreefromDiseases
-
-
💦 Be aware of co-infections: fast action & better clinical outcomes for respiratory patients Co-infection between viruses and bacteria is associated with higher severity and mortality rates. If you cough, you may easily think it’s just a cold, but you may be infected with more than one virus or bacteria and be prescribed to wrong or not enough meds. Timely diagnosis and effective treatment can enhance recovery for those suffering from respiratory infections. With Seegene’s #syndromic qPCR technology, you can avoid going through multiple tests to determine the cause of your symptoms. With respiratory pathogen qPCR assays, detect respiratory pathogens including 16 viruses, 3 Flu A subtypes, and 7 bacteria! See the full list here: https://bit.ly/3CF9jxA #Seegene #SyndromicqPCR #SyndromicPCR #coinfections #Respiratory #AWorldFreefromDiseases
-
-
🎉 We wrapped up the 2024 Seegene Gala in Seoul on June 26th with the theme "Empowering Women's Health"! We were honored to host influential experts from various countries to strengthen our global network and share Korean culture. Thank you for attending, and we look forward to welcoming you again at our next Gala event. Special Thanks to - MONGKOL BENJAPIBAL - Sayyidi Raub - KOSI (B) Sdn Bhd - Neoscience Sdn Bhd - 3i Molecular Solutions - MP Group (Thailand) Company Limited - Alatheia #Seegene #AOGIN2024 #SeegeneGala #CervicalCancer #STI #SexuallyTransmittedInfections #WomensHealth
-
-
Seegene's #syndromic PCR technologies stand out by simultaneously testing for 14 pathogens that can cause similar symptoms in a single tube!✨ This means quicker & more accurate diagnostics for those with similar symptoms requiring different therapies. Additionally, Seegene’s All-in-one platform covers the entire MDx process, setting a new paradigm by providing tailor-made diagnostic solutions to meet customer needs. We are committed to making MDx more accessible in our daily lives, aiming for a healthier future for all and a world free from diseases. 👀 Read more here: https://lnkd.in/ghrcGpXp #Seegene #SyndromicTesting #SyndromicqPCR #AllinOnePlatform #AutomatedMDx #Multiplex
-
-
⚠ In Europe, the number of #pertussis (whooping cough) cases reported in 2024 is more than ten times higher than in 2023. Whooping cough spreads through respiratory droplets with a high transmission rate within homes.💦 It is therefore crucial for all family members to receive a timely diagnosis, especially if there are vulnerable individuals like infants or the elderly in the family. #Seegene #WhoopingCough #Bordetellapertussis #Pneumonia
-
⛔ Beware of the global spread of 𝘔𝘺𝘤𝘰𝘱𝘭𝘢𝘴𝘮𝘢 𝘱𝘯𝘦𝘶𝘮𝘰𝘯𝘪𝘢𝘦! 𝘔𝘺𝘤𝘰𝘱𝘭𝘢𝘴𝘮𝘢 𝘱𝘯𝘦𝘶𝘮𝘰𝘯𝘪𝘢𝘦 peaks every 3 to 7 years, causing pneumonia that can lead to severe complications, especially in infants and the elderly. It often results in "walking pneumonia," a mild form where symptoms are not severe enough to confine patients to bed, increasing its spread. Since there is no available vaccine, early diagnosis and appropriate medical treatment for 𝘔. 𝘱𝘯𝘦𝘶𝘮𝘰𝘯𝘪𝘢𝘦 are necessary. ▶ Diagnose early with Seegene: https://lnkd.in/guSVEUPU #Seegene #Mycoplasmapneumoniae #AWorldFreefromDiseases
-
🔎 Discover #syndromic testing with Seegene! Syndromic diagnosis is the process of testing for multiple pathogens that cause similar symptoms, with just a single test. Before and during the COVID pandemic, symptom-based diagnosis and targeted testing for limited pathogens led to treatment delays and increased antimicrobial resistance globally. By testing for all suspected pathogens with a single test instead of multiple tests, syndromic diagnosis enables rapid and accurate detection and identification of infectious causes. This syndromic approach supports evidence-based diagnosis and treatment, enhancing patient care through optimized treatment decisions. #Seegene #SyndromicqPCR #SyndromicTesting #AMR #Antimicrobialstewardship #Globalhealth
-
-
#AOGIN 2024 is right around the corner, and Seegene will see you there! Under AOGIN’s theme of “Empowering Women, Together against Cervical Cancer,” we will be boosting awareness of maintaining women's health through #HPV testing. Come visit us @ booth #6 to learn more! ▶ View more info on the AOGIN website: https://www.aogin2024.com #Seegene #AOGIN2024 #CervicalCancer
-
-
Discover our OneSystem™ business, an unprecedented challenge for a world free from diseases: https://lnkd.in/gn7zRZSA Here, you can get more info on the global initiative – where it starts, how Seegene takes part, how it’s going thus far with strategic collaborators like 마이크로소프트 and Springer Nature, and more. #Seegene #AWorldFreefromDiseases #SeegeneOneSystem #OneSystemBusiness
-